
Hofseth BioCare Investor Relations Material
Latest events

Q1 2025
16 May, 2025

Q4 2024
14 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hofseth BioCare
Access all reports
Hofseth BioCare ASA is a biotechnology company that focuses on the production of high-value ingredients derived from fish. The company develops and commercializes sustainable biomarine products for human and pet health. Its product portfolio includes bioactive peptides, oils, calcium, and proteins, which are used in a variety of industries, including dietary supplements, clinical nutrition, and functional foods. Hofseth BioCare emphasizes utilizing fresh raw materials and applying a gentle enzymatic hydrolysis process to retain the nutritional properties of the fish. The company is headquartered in Ålesund, Norway, and its shares are listed on the Oslo Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
HBC
Country
🇳🇴 Norway